847 filings
Page 5 of 43
8-K
gpj5q85b mit4
10 Sep 18
Advaxis Reports Fiscal 2018 Third Quarter Business Highlights and Financial Results
12:00am
424B5
78rdp4my0i rh2pp
10 Sep 18
Prospectus supplement for primary offering
12:00am
8-K
edxky7vestha
7 Sep 18
Results of Operations and Financial Condition
12:00am
8-K
fy0t6quce ifam5bn
6 Sep 18
Advaxis Licenses ADXS-HER2 to OS Therapies for Evaluation in the Treatment of Osteosarcoma
12:00am
424B5
qy4sc9kdwzvj2jq
6 Sep 18
Prospectus supplement for primary offering
12:00am
EFFECT
8z0spxnf8yotx
30 Aug 18
Notice of effectiveness
12:00am
CORRESP
zrh kcoyi
29 Aug 18
Correspondence with SEC
12:00am
UPLOAD
v3o04piw el8j4ixuzg
28 Aug 18
Letter from SEC
12:00am
4
zogwnmp u69bq0qxy
1 Aug 18
Advaxis / ROBERT PETIT ownership change
4:30pm
8-K
exiz98zbsedxy
30 Jul 18
Advaxis Announces FDA Allowance of IND Application for ADXS-HOT Drug Candidate for Non-Small Cell Lung Cancer
12:00am
8-K
jfgoszkwgvmgpc
17 Jul 18
Other Events
4:00pm
8-K
aik zie5v2zrf7ptx
13 Jul 18
Advaxis Announces FDA Lifts Clinical Hold on Phase 1/2 Combination Study of
1:16pm
8-K
spjnegpygiki
10 Jul 18
Advaxis Provides Update on MAA Filing and ADXS-HOT Program
5:20pm
SC 13G/A
gg5le rpp83nwrz3l2gx
10 Jul 18
Advaxis, Inc.
12:00am
4
lphboe0v
2 Jul 18
Advaxis / ROBERT PETIT ownership change
4:30pm
4
hs6kxd3mzyvxopmp8 ku
27 Jun 18
Advaxis / DAVID SIDRANSKY ownership change
5:15pm
4
50za 4e8jrp7lla7wr
27 Jun 18
Advaxis / RICHARD J BERMAN ownership change
5:15pm
4
l81hj4tj5zw9xp3rb1s0
27 Jun 18
Advaxis / JAMES P PATTON ownership change
5:15pm